Cancer-Related Neuropathic Pain

Helen L Edwards; Matthew R Mulvey; Michael I Bennett

doi:10.3390/cancers11030373

Cancer-Related Neuropathic Pain

Cancers (Basel). 2019 Mar 16;11(3):373. doi: 10.3390/cancers11030373.

Authors

Helen L Edwards¹, Matthew R Mulvey², Michael I Bennett³

Affiliations

¹ Academic Unit of Palliative Care, Leeds Institute of Health Sciences, University of Leeds, Leeds LS2 9NL, UK. h.l.edwards@leeds.ac.uk.
² Academic Unit of Palliative Care, Leeds Institute of Health Sciences, University of Leeds, Leeds LS2 9NL, UK. m.r.mulvey@leeds.ac.uk.
³ Academic Unit of Palliative Care, Leeds Institute of Health Sciences, University of Leeds, Leeds LS2 9NL, UK. m.i.bennett@leeds.ac.uk.

Abstract

Neuropathic pain in cancer is common and debilitating. It is important to differentiate neuropathic pain from other cancer-related pains as it is associated with worse pain outcomes and requires different treatment strategies. This review summarises recent updates to pain classification, aetiology, pain assessment and current recommendations for treatment in patients with cancer-related neuropathic pain.

Keywords: cancer; neuropathic pain; pharmacotherapy.

Publication types

Review